From #IDWeek2026 🦠
Adults with #UrinaryTractInfections have comparable risks for treatment failure regardless of whether they are prescribed #cefpodoxime or #cefdinir upon discharge. #IDSky
@idweek.bsky.social
Adults with #UrinaryTractInfections have comparable risks for treatment failure regardless of whether they are prescribed #cefpodoxime or #cefdinir upon discharge. #IDSky
@idweek.bsky.social
Cefpodoxime and Cefdinir Yield Similar UTI Outcomes
Patients discharged from the ED with UTIs have similar treatment failure rates with cefpodoxime or cefdinir.
www.infectiousdiseaseadvisor.com
November 3, 2026 at 4:24 PM
From #IDWeek2026 🦠
Adults with #UrinaryTractInfections have comparable risks for treatment failure regardless of whether they are prescribed #cefpodoxime or #cefdinir upon discharge. #IDSky
@idweek.bsky.social
Adults with #UrinaryTractInfections have comparable risks for treatment failure regardless of whether they are prescribed #cefpodoxime or #cefdinir upon discharge. #IDSky
@idweek.bsky.social
“In an exploratory subgroup analysis of patients with a cefazolin minimum inhibitory concentration of 4 or greater, return to care occurred in 0% of patients who received cefpodoxime and 33.3% of those who received cefdinir” www.infectiousdiseaseadvisor.com/reports/cefp...
Cefpodoxime and Cefdinir Yield Similar UTI Outcomes
Patients discharged from the ED with UTIs have similar treatment failure rates with cefpodoxime or cefdinir.
www.infectiousdiseaseadvisor.com
November 4, 2026 at 11:36 PM
“In an exploratory subgroup analysis of patients with a cefazolin minimum inhibitory concentration of 4 or greater, return to care occurred in 0% of patients who received cefpodoxime and 33.3% of those who received cefdinir” www.infectiousdiseaseadvisor.com/reports/cefp...
I was feeling incredibly awful and sick. Saw the doc and got Rx for cefpodoxime. Pretty sure the illness has decided if it's going down... It's taking me with it. This medicine does not play when it comes to side effects. Blech
October 26, 2026 at 7:59 AM
I was feeling incredibly awful and sick. Saw the doc and got Rx for cefpodoxime. Pretty sure the illness has decided if it's going down... It's taking me with it. This medicine does not play when it comes to side effects. Blech
Cefpodoxime Proxetil Tablets Market Size, Share, Trends, 2035 www.marketresearchfuture.com/reports/cefp...
Cefpodoxime Proxetil Tablets Market Size, Share & Growth Report 2035 | MRFR
The Cefpodoxime Proxetil Tablets market is projected to grow from USD Billion 0.9438 in 2024 to USD Billion 1.799 by 2035, at a CAGR of 6.04% during 2025-2035.
www.marketresearchfuture.com
September 15, 2026 at 6:30 AM
Cefpodoxime Proxetil Tablets Market Size, Share, Trends, 2035 www.marketresearchfuture.com/reports/cefp...
[3/4] soft tissue infections, acute simple gonococcal urethritis and cervicitis, and perianalitis caused by Neisseria gonorrhoeae. The approval of cefpodoxime proxetil API will help the company further promote the "API + preparation" integrated strategy, create synergy with preparation
May 15, 2026 at 9:12 AM
[3/4] soft tissue infections, acute simple gonococcal urethritis and cervicitis, and perianalitis caused by Neisseria gonorrhoeae. The approval of cefpodoxime proxetil API will help the company further promote the "API + preparation" integrated strategy, create synergy with preparation
[2/4] issued by the State Food and Drug Administration. Cefpodoxime proxetil is an oral broad-spectrum third-generation cephalosporin. It is suitable for upper respiratory tract infections, lower respiratory tract infections, simple urinary tract infections, simple skin and skin and
May 15, 2026 at 9:12 AM
[2/4] issued by the State Food and Drug Administration. Cefpodoxime proxetil is an oral broad-spectrum third-generation cephalosporin. It is suitable for upper respiratory tract infections, lower respiratory tract infections, simple urinary tract infections, simple skin and skin and
[1/4] 2026-05-15 17:01:41 - [Pluto Pharmaceutical: Cefpodoxime Proxetil API is approved] Prolu Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Prodebon Pharmaceutical Co., Ltd. received the "Approval Notice for the Marketing Application of Cefpodoxime Proxetil"
May 15, 2026 at 9:12 AM
[1/4] 2026-05-15 17:01:41 - [Pluto Pharmaceutical: Cefpodoxime Proxetil API is approved] Prolu Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Prodebon Pharmaceutical Co., Ltd. received the "Approval Notice for the Marketing Application of Cefpodoxime Proxetil"
Ive never been a huge cefpodoxime fan. Not that I think it's wrong to do. Id just be more comfortable with cefixime. But, also TMP-SMX.
June 4, 2025 at 1:07 AM
Ive never been a huge cefpodoxime fan. Not that I think it's wrong to do. Id just be more comfortable with cefixime. But, also TMP-SMX.
There was a total of 185 cefazolin-resistant Enterobacterales isolates. Among these isolates, 88 were cefazolin-resistant but ceftriaxone susceptible; susceptibilities to oral cephalosporins were as follows: cefuroxime (79, 90%), cefixime (81, 92%), cefpodoxime (62, 71%), and cefdinir (77, 88%).
January 3, 2025 at 3:00 AM
There was a total of 185 cefazolin-resistant Enterobacterales isolates. Among these isolates, 88 were cefazolin-resistant but ceftriaxone susceptible; susceptibilities to oral cephalosporins were as follows: cefuroxime (79, 90%), cefixime (81, 92%), cefpodoxime (62, 71%), and cefdinir (77, 88%).
journals.asm.org/doi/10.1128/...
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? | Antimicrobial Agents and Chemotherapy
There is a growing body of evidence supporting early transition to oral antibiotic
therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI)
(1–3). Most available data fo...
journals.asm.org
January 3, 2025 at 2:58 AM
journals.asm.org/doi/10.1128/...
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
The reliability of ceftriaxone for inferring susceptibility to higher-generation oral cephalosporins is unknown. Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%)…
Is Cefpodoxime Active? Check out this week’s KASIC pearl to learn about Ceftriaxone Guided IV to PO kymdro.org/kasic/?p=8544
#IDTSky #AntimicrobialResistance #antimicrobialstewardship #rxsky #pharmacy #FOAMed #NPs #PAs
#IDTSky #AntimicrobialResistance #antimicrobialstewardship #rxsky #pharmacy #FOAMed #NPs #PAs
September 13, 2025 at 3:38 PM
Is Cefpodoxime Active? Check out this week’s KASIC pearl to learn about Ceftriaxone Guided IV to PO kymdro.org/kasic/?p=8544
#IDTSky #AntimicrobialResistance #antimicrobialstewardship #rxsky #pharmacy #FOAMed #NPs #PAs
#IDTSky #AntimicrobialResistance #antimicrobialstewardship #rxsky #pharmacy #FOAMed #NPs #PAs
I'd wager clinical cure with oral cefixime/cefpodoxime would not be different than IM ceftriaxone if we actually gave more than a single dose (e.g., maintain a similar time>MIC). No reason to think it doesn't get to the rectum and throat if dose/duration leads to favorable exposure
December 12, 2025 at 7:39 PM
I'd wager clinical cure with oral cefixime/cefpodoxime would not be different than IM ceftriaxone if we actually gave more than a single dose (e.g., maintain a similar time>MIC). No reason to think it doesn't get to the rectum and throat if dose/duration leads to favorable exposure
Remind me again why we don't use oral cefixime (availability not withstanding) or cefpodoxime for gonorrhea? We preferentially rx chlamydia for 7 days now with doxy, so save me the single dose argument.
MIC creep ("reduced susceptibility" from 1.5 decades ago) is not a good answer! #IDSky #MedSky
MIC creep ("reduced susceptibility" from 1.5 decades ago) is not a good answer! #IDSky #MedSky
December 12, 2025 at 3:27 PM
Increasing the single dose of a time dependent antibiotic feels like a losing strategy
Why not 3 days of cefixime or cefpodoxime?
No laws written that I know of that require single dose STI treatment. Plus we routinely do 7d for chlamydia now anyway. I think an oral regimen would increase access
Why not 3 days of cefixime or cefpodoxime?
No laws written that I know of that require single dose STI treatment. Plus we routinely do 7d for chlamydia now anyway. I think an oral regimen would increase access
November 11, 2024 at 4:10 AM
Increasing the single dose of a time dependent antibiotic feels like a losing strategy
Why not 3 days of cefixime or cefpodoxime?
No laws written that I know of that require single dose STI treatment. Plus we routinely do 7d for chlamydia now anyway. I think an oral regimen would increase access
Why not 3 days of cefixime or cefpodoxime?
No laws written that I know of that require single dose STI treatment. Plus we routinely do 7d for chlamydia now anyway. I think an oral regimen would increase access
Answer: d
Pivmecillinam is also considered a first-line option for empiric treatment of uUTI in nonpregnant women. Amoxicillin/clavulanate, cefpodoxime, and cefadroxil are second-line options.
Pivmecillinam is also considered a first-line option for empiric treatment of uUTI in nonpregnant women. Amoxicillin/clavulanate, cefpodoxime, and cefadroxil are second-line options.
April 21, 2026 at 8:20 PM
Answer: d
Pivmecillinam is also considered a first-line option for empiric treatment of uUTI in nonpregnant women. Amoxicillin/clavulanate, cefpodoxime, and cefadroxil are second-line options.
Pivmecillinam is also considered a first-line option for empiric treatment of uUTI in nonpregnant women. Amoxicillin/clavulanate, cefpodoxime, and cefadroxil are second-line options.
#OTILT I learned that ciprofloxacin was found to be more effective than cefpodoxime for uncomplicated UTIs in this 2013 RCT. However, the cefpodoxime dose and duration were lower than what is recommended in Brigham’s guidelines, which may have impacted its effectiveness. @jeffpears0n.bsky.social
Cefpodoxime vs Ciprofloxacin for Short-Course Treatment of Acute Uncomplicated Cystitis: A Randomized Trial
Although fluoroquinolones remain the most reliable urinary antimicrobial, resistance rates have increased and effective fluoroquinolone-sparing antimicrobials are needed. To determine whether cefpodox...
pmc.ncbi.nlm.nih.gov
May 20, 2025 at 4:50 PM
#OTILT I learned that ciprofloxacin was found to be more effective than cefpodoxime for uncomplicated UTIs in this 2013 RCT. However, the cefpodoxime dose and duration were lower than what is recommended in Brigham’s guidelines, which may have impacted its effectiveness. @jeffpears0n.bsky.social
@mackaracka.bsky.social I’m back home so yay!!! I have an infection:coag-neg staphylococcus. Been getting IV antibiotics. Now will take cefpodoxime (Vantin)for 10 days. Did I mention I’m back home???
a cartoon of snoopy dancing with the words yay in red
ALT: a cartoon of snoopy dancing with the words yay in red
media.tenor.com
March 25, 2025 at 8:54 PM
@mackaracka.bsky.social I’m back home so yay!!! I have an infection:coag-neg staphylococcus. Been getting IV antibiotics. Now will take cefpodoxime (Vantin)for 10 days. Did I mention I’m back home???
"Cefpodoxime proxetil and potassium clavulanate" has an oddly soothing sound when you say it aloud
January 25, 2025 at 11:17 PM
"Cefpodoxime proxetil and potassium clavulanate" has an oddly soothing sound when you say it aloud
As someone who grew up with tonsillitis/pharyngitis/sinusitis - cefpodoxime proxetil
January 25, 2025 at 11:13 PM
As someone who grew up with tonsillitis/pharyngitis/sinusitis - cefpodoxime proxetil
3. 3rd Gen. Cephalosporins
After DINIR celebration, TRI (3) to FIX TAXes– DIMEs, pTIZO, PERA, & DOcX files
CefDINIR
CefTRIaxone
CeFIXime
CefoTAXime
CeftaziDIME
CefoPERAzone
CefpoDOXime
CeftizOXime
🎨 cyrlart
After DINIR celebration, TRI (3) to FIX TAXes– DIMEs, pTIZO, PERA, & DOcX files
CefDINIR
CefTRIaxone
CeFIXime
CefoTAXime
CeftaziDIME
CefoPERAzone
CefpoDOXime
CeftizOXime
🎨 cyrlart
November 15, 2024 at 12:50 PM
3. 3rd Gen. Cephalosporins
After DINIR celebration, TRI (3) to FIX TAXes– DIMEs, pTIZO, PERA, & DOcX files
CefDINIR
CefTRIaxone
CeFIXime
CefoTAXime
CeftaziDIME
CefoPERAzone
CefpoDOXime
CeftizOXime
🎨 cyrlart
After DINIR celebration, TRI (3) to FIX TAXes– DIMEs, pTIZO, PERA, & DOcX files
CefDINIR
CefTRIaxone
CeFIXime
CefoTAXime
CeftaziDIME
CefoPERAzone
CefpoDOXime
CeftizOXime
🎨 cyrlart
Stability and Efficacy: The Global Outlook for the Cefpodoxime Proxetil Tablets Market
The cefpodoxime proxetil tablets market continues to be a cornerstone of the anti-infective sector, providing a reliable oral option for a broad range of bacterial infections. As a third-generation…
The cefpodoxime proxetil tablets market continues to be a cornerstone of the anti-infective sector, providing a reliable oral option for a broad range of bacterial infections. As a third-generation…
Stability and Efficacy: The Global Outlook for the Cefpodoxime Proxetil Tablets Market
The cefpodoxime proxetil tablets market continues to be a cornerstone of the anti-infective sector, providing a reliable oral option for a broad range of bacterial infections. As a third-generation cephalosporin, its stability against many beta-lactamase enzymes makes it an essential tool for treating respiratory and urinary tract infections in both adult and pediatric populations. Overview Cefpodoxime Proxetil is an oral prodrug that is converted in the body to its active form, cefpodoxime.
www.news24.ph
January 11, 2026 at 11:02 AM
Stability and Efficacy: The Global Outlook for the Cefpodoxime Proxetil Tablets Market
The cefpodoxime proxetil tablets market continues to be a cornerstone of the anti-infective sector, providing a reliable oral option for a broad range of bacterial infections. As a third-generation…
The cefpodoxime proxetil tablets market continues to be a cornerstone of the anti-infective sector, providing a reliable oral option for a broad range of bacterial infections. As a third-generation…
Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%) based on disk diffusion results for 409 consecutive Enterobacterales bloodstream isolates from unique patients #idsky
December 31, 2024 at 7:35 PM
Overall, ceftriaxone susceptibility predicted susceptibility to cefuroxime (89%), cefdinir (86%), cefpodoxime (90%), and cefixime (94%) based on disk diffusion results for 409 consecutive Enterobacterales bloodstream isolates from unique patients #idsky
She's on cefpodoxime, ketoconzale, apoquel, antibiotic eardrops, and animax ointment for quite some time. None of it is helping 😕
December 6, 2025 at 4:05 AM
She's on cefpodoxime, ketoconzale, apoquel, antibiotic eardrops, and animax ointment for quite some time. None of it is helping 😕